epcoritamab
abbvie,genmab
['epcoritamab', 'dlbcl']
improvement in the quality of response to salvage cit adding epcoritamab in dlbcl patients eligible for hdt/asct #ash22 #immunotherapy #bites #epcoritamab 
Hematologist, MD
Vall d'Hebron Hospital